https://dxm-atlas.org/en/interactions/duloxetine/
CompareKey points for this combination
Inhibition of serotonin and noradrenaline reuptake, together with CYP2D6 inhibition. The review’s numerical PHI judgment rests on limited data for this combination [2].
General concepts in this text
Reuptake
Return of a released neurotransmitter into a cell through a transporter protein.
Allows neurotransmitter recycling.
Sources: Reuptake
- OpenStax: General Neurochemistry Principles · Introduction to Behavioral Neuroscience, published 2024-11-13
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
Serotonin
A neurotransmitter: a substance that carries a chemical signal from a nerve cell.
There are different serotonin receptors in the brain and other parts of the body. The response to the signal depends on the receptor and its location.
Sources: Serotonin
- OpenStax: Neural Communication · Introduction to Behavioral Neuroscience, published 2024-11-13
- OpenStax: Neurotransmitters Made from Amino Acids — Serotonin · Introduction to Behavioral Neuroscience, published 2024-11-13
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
Can the amount reaching the body change?
ⓘ
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
How can the effects add up?
ⓘ
SERT
A transporter protein involved in serotonin reuptake.
Inhibiting transport differs from acting on receptors.
Sources: SERT
- IUPHAR Pharmacology Education Project: Receptors · Live page accessed 2026-10-12; revision label unavailable
ⓘ
Autonomic nervous system
The part of the nervous system that regulates the heart, internal organs and glands without conscious control of each response.
The sympathetic division is part of this system. In a response to threat it can increase heart rate and sweating.
Sources: Autonomic nervous system
- Anatomy and Physiology 2e, §15.1 Divisions of the Autonomic Nervous System · Second edition; book publication date 20 April 2022. No separately verified webpage revision date.
Sources
Check the review’s wording
SNRI effects plus CYP2D6 inhibition; limited quantitative assessment of the pair [2]